Table 2 List of main studies compared between one-stage and two-stage procedures in TBBAVF.
Authors | Year | Study type | Number | Maturation rate (%) | Secondary patency at 2 years | Complication | Recommendation | ||
---|---|---|---|---|---|---|---|---|---|
One stage | Two stage | One stage | Two stage | ||||||
El Mallah | 1998 | Randomized | One stage 20 | 60 | 90 | Two stage | |||
Two stage 20 | |||||||||
Hossny | 2003 | Retrospective | One-stage transposition 40 | Transposition 82.8 | Elevation 68.4 | Hematoma: 26.3% in elevation group | |||
One-stage elevation 20 | Elevation 70 | ||||||||
Two-stage elevation 20 | |||||||||
Kakkos | 2010 | Retrospective | One-stage transposition 76 | 85** | 82** | Complications: higher in one-stage method | Two stage | ||
Two-stage transposition 98 (72)* | 10 in two-stage group did not attain second stage | ||||||||
Reynolds | 2011 | Retrospective | One-stage transposition 60 | 77.1 | 90.9 | 41 | 94 | 30 days complications: similar in both groups | Two stage |
Two-stage tansposition 30 | |||||||||
Syed | 2012 | Retrospective | 79 | 82 | 81 | 27 | |||
Vrakas | 2013 | Retrospective | One-stage transposition 65 | 55 | 58 | 57 | 77 | Complications: similar in both groups | Two stage |
Two-stage elevation 84 | |||||||||
Ozcan | 2013 | Retrospective | One stage 47 (basilic vein >3 mm) | 66 | 77 | 98 | 98 | Complications: higher in one-stage method | Two stage |
Two stage 59 (basilic vein <3 mm) | |||||||||
Robertson | 2013 | Retrospective | One stage 29 | 76 | 84 | 86.2*** | 91.6*** | One stage | |
Two stage 44 | |||||||||
Agarwal | 2014 | Retrospective | One stage 61 | 90 | 75 | 75 | 71 | Required interventions: similar in both groups | |
Two stage 83 | |||||||||
Kakkos | 2015 | Randomized | One-stage transposition 9 | 33 | 100 | 44 | 86 | Two stage | |
Two-stage transposition 7 | |||||||||
Ghaffarian | 2017 | Retrospective | One stage 57 | 44 | 73 | Complications: similar in both groups | Two stage | ||
Two stage 74 | Two stage was durable and cost-effective |
*: 72 out of 98 underwent a second-stage operation; **: including lost or refuse patients; ***: secondary patency at 6 months